Skip to main content
. 2021 Jan 18;21:77. doi: 10.1186/s12885-020-07753-w

Fig. 3.

Fig. 3

Survival of patients with both low SMI (sarcopenia) and low SMD compared to other patients. Group A: High SMI and high SMD; Group B: High SMI and low SMD; Group C: Low SMI and high SMD; Group D: Low SMI and low SMD. Patients with low SMI and low SMD showed poorer overall survival than those with either of these conditions or neither one (a, c). Copresence of low SMI and low SMD were not associated with progression-free survival (b, d)